Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Neoplasm Metastasis 2Endometrial Neoplasms 2Bile Duct Neoplasms 2Stomach Neoplasms 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Docetaxel 4Cetuximab 4pembrolizumab 3Trastuzumab 3Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Biopsy 3trastuzumab deruxtecan 2sargramostim 2Taxes 2SS1(dsFv)PE38 2Radiotherapy 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Carboplatin 2Capecitabine 2zanidatamab 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1tanespimycin 1spartalizumab 1pertuzumab 1oncogene protein E7, Human papillomavirus type 16 1neratinib 1mercaptoundecahydrododecaborate 1larotrectinib 1fluoromisonidazole 1entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × ceralasertib × Gastrointestinal × Clear all
NCT04704661 2026-05-13

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

National Cancer Institute (NCI)

Phase 1 Active not recruiting
51 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcoma

Breast Neoplasms, Carcinosarcoma, Colonic Neoplasms, Neoplasm Metastasis, Salivary Gland Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡